AQR Capital discloses 5.54% ownership in Tonix Pharmaceuticals (TNXP) via Schedule 13G

Rhea-AI Filing Summary

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC report beneficial ownership of 882,595 shares of Tonix Pharmaceuticals Holding Corp. common stock, representing 5.54% of the class. They report shared voting power over 866,867 shares and shared dispositive power over 882,595 shares, with no sole voting or dispositive power. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC, and the Schedule 13G is filed on behalf of both entities.

Key Figures

Shares beneficially owned: 882,595 shares Percent of class: 5.54% Shared voting power: 866,867 shares +3 more

6 metrics

Shares beneficially owned 882,595 shares Beneficial ownership of Tonix Pharmaceuticals common stock reported by AQR entities

Percent of class 5.54% Portion of Tonix Pharmaceuticals common stock class beneficially owned

Shared voting power 866,867 shares Shares of Tonix Pharmaceuticals over which AQR entities share voting power

Shared dispositive power 882,595 shares Shares of Tonix Pharmaceuticals over which AQR entities share dispositive power

Sole voting power 0 shares Tonix Pharmaceuticals shares over which AQR entities have sole voting power

Sole dispositive power 0 shares Tonix Pharmaceuticals shares over which AQR entities have sole dispositive power

Key Terms

beneficially owned, shared voting power, shared dispositive power, parent holding company or control person

4 terms

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 882,595"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"Shared Voting Power 866,867.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 882,595.00"

parent holding company or control person financial

"filed this schedule, pursuant to (ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary."

FAQ

How much of Tonix Pharmaceuticals (TNXP) does AQR Capital report owning?

AQR Capital entities report beneficial ownership of 882,595 shares of Tonix Pharmaceuticals common stock, representing 5.54% of the outstanding class as stated in the Schedule 13G filing.

What voting power does AQR Capital have in Tonix Pharmaceuticals (TNXP)?

The AQR entities report shared voting power over 866,867 shares of Tonix Pharmaceuticals and no sole voting power, indicating decisions to vote these shares are made jointly, not individually.

What dispositive power does AQR Capital hold over TNXP shares?

AQR Capital entities report shared dispositive power over 882,595 shares of Tonix Pharmaceuticals and no sole dispositive power, meaning authority to dispose of these shares is held on a shared basis.

Which AQR entities are listed as reporting persons for Tonix Pharmaceuticals (TNXP)?

The filing lists AQR Capital Management, LLC and AQR Capital Management Holdings, LLC as reporting persons, with AQR Capital Management, LLC described as a wholly owned subsidiary of AQR Capital Management Holdings, LLC.

Why is this Tonix Pharmaceuticals (TNXP) Schedule 13G filing significant?

The Schedule 13G shows that AQR Capital entities hold a 5.54% beneficial stake in Tonix Pharmaceuticals, crossing the 5% threshold that requires public disclosure of ownership and voting/dispositive powers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 09:18 AM Accepted by SEC EDGAR 08/13/2026 - 09:17 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Tonix Pharmaceuticals Holding Corp.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

890260839

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 890260839

1

Names of Reporting Persons

AQR Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 866,867.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 882,595.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

882,595.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.54 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 890260839

1

Names of Reporting Persons

AQR Capital Management Holdings, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 866,867.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 882,595.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

882,595.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.54 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Tonix Pharmaceuticals Holding Corp.
(b)	Address of issuer's principal executive offices: 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NEW JERSEY 07922
Item 2.
(a)	Name of person filing: AQR Capital Management, LLC AQR Capital Management Holdings, LLC
(b)	Address or principal business office or, if none, residence: ONE GREENWICH PLAZA SUITE 130 Greenwich, Connecticut 06830
(c)	Citizenship: AQR Capital Management, LLC - UNITED STATES AQR Capital Management Holdings, LLC - UNITED STATES
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 890260839
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 882,595
(b)	Percent of class: 5.54 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: AQR Capital Management, LLC - 0 AQR Capital Management Holdings, LLC - 0
	(ii) Shared power to vote or to direct the vote: AQR Capital Management, LLC - 866,867 AQR Capital Management Holdings, LLC - 866,867
	(iii) Sole power to dispose or to direct the disposition of: AQR Capital Management, LLC - 0 AQR Capital Management Holdings, LLC - 0
	(iv) Shared power to dispose or to direct the disposition of: AQR Capital Management, LLC - 882,595 AQR Capital Management Holdings, LLC - 882,595
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Item 2(a) above.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

AQR Capital Management, LLC

Signature:	Henry Parkin
Name/Title:	Authorized Signatory
Date:	08/13/2026

AQR Capital Management Holdings, LLC

Signature:	Henry Parkin
Name/Title:	Authorized Signatory
Date:	08/13/2026

Exhibit Information

AQR Capital Management Holdings, LLC and AQR Capital Management, LLC hereby agree that this Schedule 13G is filed on behalf of each of the parties. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.